首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1953981

日本體外診斷市場報告：按檢測類型、產品類型、便利性、應用、最終用戶和地區分類（2026-2034年）

Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2026-2034

出版日期: 2026年02月01日 | 出版商:

IMARC | 英文 149 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本體外診斷市場規模達51億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到63億美元，2026年至2034年的複合年成長率為2.30%。推動市場成長的關鍵因素包括人口老化、技術快速進步、醫療意識增強、政府主導的措施不斷擴大、個人化醫療的發展以及對研發活動的日益重視。

體外診斷（IVD）是指對取自人體的生物檢體進行的各種醫學檢測。這些檢測透過分析體外血液、尿液和組織樣本來檢測疾病、感染疾病和其他病症。體外診斷廣泛應用於實驗室、醫院和專科診所，對醫療決策、病患監測和個人化治療至關重要。其在醫療保健領域的廣泛應用有助於早期診斷和精準醫療，使醫護人員能夠做出明智及時的決策。作為現代醫療保健系統的重要組成部分，體外診斷促進了預防醫學和治療醫學的發展，改善了患者的整體健康。它們還有助於提高醫療效率、促進早期發現並降低醫療成本。此外，體外診斷也用於監測慢性疾病並輔助治療決策。

日本體外診斷市場趨勢：

隨著老齡化社會的加劇，人們對更全面、更常規的醫療檢測的需求日益成長，這是推動市場成長的關鍵因素之一。同時，糖尿病、心血管疾病和癌症等與老齡化相關的疾病盛行率也在上升。反過來，這又透過對體外診斷（IVD）檢測的需求成長，推動了市場成長，這些疾病的診斷和治療需要IVD檢測。此外，分子診斷、照護現場檢測（POC）和自動化技術等先進技術的進步，正在提高IVD檢測的準確性、速度和可及性。政府加大力度推動醫療創新，並推出用戶友善、個人化的IVD解決方案，也促進了這一趨勢。此外，隨著消費者越來越積極主動地管理自身健康，他們越來越重視預防保健，成長要素了對健康相關診斷檢測和個人化醫療解決方案的需求。此外，向個人化醫療的快速轉型和分子診斷技術的進步，正在塑造日本IVD市場的未來。此外，對研發的日益重視以及診斷公司與研究機構之間合作的加強，為市場帶來了盈利的成長機會。同時，巨量資料和人工智慧在診斷領域的整合、分析能力的提升以及個人化醫療服務的推行，也為市場成長創造了盈利條件。

日本體外診斷市場細分：

按測試類型分析：

本報告解答的關鍵問題：

日本體外診斷市場目前發展狀況如何？您預計未來幾年它將如何發展？
新冠疫情對日本體外診斷市場產生了哪些影響？
日本體外診斷市場依檢測類型分類的組成是怎樣的？
日本體外診斷市場依產品分類的組成是怎樣的？
日本體外診斷市場按利用率分類的市場組成為何？
日本體外診斷市場按應用領域是如何分類的？
日本體外診斷市場依最終用戶分類的組成是怎樣的？
日本體外診斷市場價值鏈的各個階段有哪些？
日本體外診斷市場的主要促進因素和挑戰是什麼？
日本體外診斷市場的結構是怎麼樣的？主要參與者有哪些？
日本體外診斷市場的競爭程度如何？

The Japan in vitro diagnostics market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2.30% during 2026-2034. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.

In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.

Japan In Vitro Diagnostics Market Trends:

The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.

Japan In Vitro Diagnostics Market Segmentation:

Test Type Insights:

Clinical Chemistry
Molecular Diagnostics
Immunodiagnostics
Hematology
Others

Product Insights:

Reagents and Kits
Instruments

Usability Insights:

Disposable IVD Devices
Reusable IVD Devices

Application Insights:

Infectious Disease
Diabetes
Cancer/Oncology
Cardiology
Autoimmune Disease
Nephrology
Others

End User Insights:

Hospitals Laboratories
Clinical Laboratories
Point-Of-Care Testing Centers
Academic Institutes
Patients
Others

Regional Insights:

Kanto Region
Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include the Kanto Region, Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region and Shikoku Region.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan in vitro diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan in vitro diagnostics market?
What is the breakup of the Japan in vitro diagnostics market on the basis of test type?
What is the breakup of the Japan in vitro diagnostics market on the basis of product?
What is the breakup of the Japan in vitro diagnostics market on the basis of usability?
What is the breakup of the Japan in vitro diagnostics market on the basis of application?
What is the breakup of the Japan in vitro diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan in vitro diagnostics market?
What are the key driving factors and challenges in the Japan in vitro diagnostics market?
What is the structure of the Japan in vitro diagnostics market and who are the key players?
What is the degree of competition in the Japan in vitro diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan In Vitro Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan In Vitro Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan In Vitro Diagnostics Market - Breakup by Test Type

6.1 Clinical Chemistry
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 Molecular Diagnostics
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Immunodiagnostics
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)
6.4 Hematology
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2020-2025)
- 6.4.3 Market Forecast (2026-2034)
6.5 Others
- 6.5.1 Historical and Current Market Trends (2020-2025)
- 6.5.2 Market Forecast (2026-2034)

7 Japan In Vitro Diagnostics Market - Breakup by Product

7.1 Reagents and Kits
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Instruments
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan In Vitro Diagnostics Market - Breakup by Usability

8.1 Disposable IVD Devices
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Reusable IVD Devices
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)

9 Japan In Vitro Diagnostics Market - Breakup by Application

9.1 Infectious Disease
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Forecast (2026-2034)
9.2 Diabetes
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Forecast (2026-2034)
9.3 Cancer/Oncology
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Forecast (2026-2034)
9.4 Cardiology
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Forecast (2026-2034)
9.5 Autoimmune Disease
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Forecast (2026-2034)
9.6 Nephrology
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Forecast (2026-2034)
9.7 Others
- 9.7.1 Historical and Current Market Trends (2020-2025)
- 9.7.2 Market Forecast (2026-2034)

10 Japan In Vitro Diagnostics Market - Breakup by End User

10.1 Hospitals Laboratories
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2020-2025)
- 10.1.3 Market Forecast (2026-2034)
10.2 Clinical Laboratories
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2020-2025)
- 10.2.3 Market Forecast (2026-2034)
10.3 Point-of-care Testing Centers
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2020-2025)
- 10.3.3 Market Forecast (2026-2034)
10.4 Academic Institutes
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2020-2025)
- 10.4.3 Market Forecast (2026-2034)
10.5 Patients
- 10.5.1 Overview
- 10.5.2 Historical and Current Market Trends (2020-2025)
- 10.5.3 Market Forecast (2026-2034)
10.6 Others
- 10.6.1 Historical and Current Market Trends (2020-2025)
- 10.6.2 Market Forecast (2026-2034)

11 Japan In Vitro Diagnostics Market - Breakup by Region

11.1 Kanto Region
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2020-2025)
- 11.1.3 Market Breakup by Test Type
- 11.1.4 Market Breakup by Product
- 11.1.5 Market Breakup by Usability
- 11.1.6 Market Breakup by Application
- 11.1.7 Market Breakup by End User
- 11.1.8 Key Players
- 11.1.9 Market Forecast (2026-2034)
11.2 Kinki Region
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2020-2025)
- 11.2.3 Market Breakup by Test Type
- 11.2.4 Market Breakup by Product
- 11.2.5 Market Breakup by Usability
- 11.2.6 Market Breakup by Application
- 11.2.7 Market Breakup by End User
- 11.2.8 Key Players
- 11.2.9 Market Forecast (2026-2034)
11.3 Central/Chubu Region
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2020-2025)
- 11.3.3 Market Breakup by Test Type
- 11.3.4 Market Breakup by Product
- 11.3.5 Market Breakup by Usability
- 11.3.6 Market Breakup by Application
- 11.3.7 Market Breakup by End User
- 11.3.8 Key Players
- 11.3.9 Market Forecast (2026-2034)
11.4 Kyushu-Okinawa Region
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2020-2025)
- 11.4.3 Market Breakup by Test Type
- 11.4.4 Market Breakup by Product
- 11.4.5 Market Breakup by Usability
- 11.4.6 Market Breakup by Application
- 11.4.7 Market Breakup by End User
- 11.4.8 Key Players
- 11.4.9 Market Forecast (2026-2034)
11.5 Tohoku Region
- 11.5.1 Overview
- 11.5.2 Historical and Current Market Trends (2020-2025)
- 11.5.3 Market Breakup by Test Type
- 11.5.4 Market Breakup by Product
- 11.5.5 Market Breakup by Usability
- 11.5.6 Market Breakup by Application
- 11.5.7 Market Breakup by End User
- 11.5.8 Key Players
- 11.5.9 Market Forecast (2026-2034)
11.6 Chugoku Region
- 11.6.1 Overview
- 11.6.2 Historical and Current Market Trends (2020-2025)
- 11.6.3 Market Breakup by Test Type
- 11.6.4 Market Breakup by Product
- 11.6.5 Market Breakup by Usability
- 11.6.6 Market Breakup by Application
- 11.6.7 Market Breakup by End User
- 11.6.8 Key Players
- 11.6.9 Market Forecast (2026-2034)
11.7 Hokkaido Region
- 11.7.1 Overview
- 11.7.2 Historical and Current Market Trends (2020-2025)
- 11.7.3 Market Breakup by Test Type
- 11.7.4 Market Breakup by Product
- 11.7.5 Market Breakup by Usability
- 11.7.6 Market Breakup by Application
- 11.7.7 Market Breakup by End User
- 11.7.8 Key Players
- 11.7.9 Market Forecast (2026-2034)
11.8 Shikoku Region
- 11.8.1 Overview
- 11.8.2 Historical and Current Market Trends (2020-2025)
- 11.8.3 Market Breakup by Test Type
- 11.8.4 Market Breakup by Product
- 11.8.5 Market Breakup by Usability
- 11.8.6 Market Breakup by Application
- 11.8.7 Market Breakup by End User
- 11.8.8 Key Players
- 11.8.9 Market Forecast (2026-2034)

12 Japan In Vitro Diagnostics Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Services Offered
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Services Offered
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Services Offered
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Services Offered
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Services Offered
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan In Vitro Diagnostics Market - Industry Analysis

14.1 Drivers, Restraints, and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis